From the Journals

Corticosteroid Use Linked to Weight, Waist Gains

In a study of over 80,000 adults, long-term corticosteroid use—including inhaled and topical forms—was associated with gradual weight gain and waist enlargement, especially in women and those with overweight or obesity.

Share

  • 1

    Long-term corticosteroid use linked to increases in body weight and waist circumference.

  • 2

    Female individuals and those with overweight or obesity are notably affected.

  • 3

    Both local and systemic corticosteroids can lead to long-term changes in body weight and central adiposity.

  • 4

    Study limitations included reliance on self-reported medication use and lack of complete data on diet and physical activity.

  • 5

    Large sample size and repeated anthropometric measurements supported the strength of the findings.

Original Source(s)

Corticosteroid Use Linked to Weight, Waist Gains

In a study of over 80,000 adults, long-term corticosteroid use—including inhaled and topical forms—was associated with gradual weight gain and waist enlargement, especially in women and those with overweight or obesity.

  • by Stanley Gajete

  • May 7, 2025

  • 3 min

Related Content

Oral GLP-1s Won’t Win on Convenience – They’ll Win on CMC 

GLP-1 peptides validated the science. CMC will validate the small molecule modality for GLP-1 efficacy, scalability, and access.

GLP-1 Analysis: Riding the Wave of Peptide Innovation

The remarkable commercial success of GLP-1 receptor agonists is fueling investment, accelerating science, and creating new analytical challenges. Here, we outline the hurdles these peptides present, explore methods for impurity profiling and structural characterization, and consider strategies to keep pace with this fast-moving field.

FDA Drops Warning From GLP-1 RAs

The FDA asked manufacturers to remove suicidal ideation and behavior warnings from select GLP-1 RAs after a comprehensive safety evaluation.